Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV004997563 | SCV005620343 | likely benign | Autosomal recessive limb-girdle muscular dystrophy | 2025-01-08 | reviewed by expert panel | curation | The NM_000231.3: c.1-3C>T variant is an intronic SGCG variant that is located in a splice region. The computational splicing predictor SpliceAI gives a score of 0.02 for acceptor loss, suggesting that the variant has no impact on splicing since it does not exceed the designated LGMD VCEP threshold (≤0.05) (BP4). The highest minor allele frequency of this variant is 0.0003793 (6/15820 exome chromosomes) in the African/African American population in gnomAD v2.1.1, which is greater than the ClinGen LGMD threshold (≤0.00009) for PM2_Supporting, and therefore does not meet this criterion (PM2_Supporting, BA1, BS1 criteria not met). In summary, this variant meets the criteria to be classified as Likely Benign for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen Limb-Girdle Muscular Dystrophy VCEP (LGMD VCEP specifications version 1.0.0; 01/08/2025): BP4. |
Athena Diagnostics | RCV000992969 | SCV001145597 | uncertain significance | not provided | 2019-06-18 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001272915 | SCV002776529 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2C | 2021-11-10 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001272915 | SCV001455339 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2C | 2020-09-16 | no assertion criteria provided | clinical testing |